Corona vaccine … a “important request” from Pfizer gives great hope

<div id="firstBodyDiv" data-bind-html-content-type="article" data-bind-html-compile="article.body" data-first-article-body="

Submit application comes to US Food and Drug Administration Days after the announcement Pfizer And its German partner Biontech Results Final experiences, Which showed that the vaccine is effective in preventing Covid-19 95 percent without any safety concerns.

Shares rose Pfizer Inc. By 1.6 percent, shares of Biontech Company By 6%, after news of the possibility of a vaccine being available soon, which raised hopes of ending a pandemic that killed more than a quarter of a million people in United State And more than 1.3 million around the world.

The request also includes safety data for 100 children between the ages of 12 and 15, and the company said that 45 percent of the participants in the US trials are between the ages of 56 and 85.

وقال US Secretary of HealthAlex Azar, for Network "CBS" Newsletter if the data is strong, "We may have literally weeks before a license for a vaccine that is 95 percent effective".

The companies expect the Food and Drug Administration to grant approval for emergency use by mid-December.

They said they would start shipping the doses immediately, and Pfizer said it expects to have 50 million vaccine doses ready this year, enough to protect 25 million people.

“>

Submit application comes to US Food and Drug Administration Days after the announcement Pfizer And its German partner Biontech Results Final experiences, Which showed that the vaccine is effective in preventing Covid-19 95 percent without any safety concerns.

Shares rose Pfizer Inc. By 1.6 percent, shares of Biontech Company By 6%, after news of the possibility of a vaccine being available soon, which raised hopes of ending a pandemic that killed more than a quarter of a million people in United State And more than 1.3 million around the world.

The request also includes safety data for 100 children between the ages of 12 and 15, and the company said that 45 percent of the participants in the US trials are between the ages of 56 and 85.

وقال US Secretary of HealthAlex Azar, for CBS News The data if strong, “we might have literally weeks before getting a license for a vaccine that is 95 percent effective.”

The companies expect the Food and Drug Administration to grant approval for emergency use by mid-December.

They said they would start shipping the doses immediately, and Pfizer said it expects to have 50 million vaccine doses ready this year, enough to protect 25 million people.

.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Trending